Teleflex To Dominate Laryngeal Mask Market Following $276 Mil. LMA Buy
This article was originally published in The Gray Sheet
LMA International, which controls 85% of the global market for laryngeal masks, will complement Teleflex’s existing anesthesia and respiratory businesses. The masks support the airway of patients undergoing surgical procedures and other life-saving interventions.
You may also be interested in...
The purchase price of $56 a share in cash is a modest 16% premium over Vascular Solutions' 90-day average price. Vascular Solutions' CEO says uncertainty about the future leadership of the company compelled it to consider acquisition offers.
Device companies raised a total of $801 million in 2012’s third quarter, an 18% drop from Q2’s $977 million. Approximately $2.6 billion was spent on device acquisitions, exactly $2 billion less than Q2’s total. Diagnostic/research company financings totaled $484 million during Q3 2012, up from last quarter’s $336 million. And while diagnostic/research M&A activity was not as prolific as last quarter, tech transfer deals are seeing a resurgence.
Teleflex buys Hotspur, unloads OEM ortho unit. Life Technologies snaps up Navigenics. Accuray acquires Morphormics. More news briefs.